Evaluation of antiinflammatory activity of the total flavonoids of Laggera pterodonta on acute and chronic inflammation models

Phytotherapy Research

Volumn 20, Issue 7, 2006, Pages 585-590

  Wu, Yihang ^a   Zhou, Changxin ^a   Li, Xiangping ^a   Song, Liyan ^a   Wu, Xiumei ^b   Lin, Wenyan ^a   Chen, Haiyong ^a   Bai, Hua ^b   Zhao, Jun ^a   Zhang, Rongping ^c   Sun, Handong ^d   Zhao, Yu ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b Zhejiang Hisun Naturelite Pharmaceutical R and D Co Ltd   (China)

^c KUNMING MEDICAL UNIVERSITY   (China)

^d KUNMING INSTITUTE OF BOTANY   (China)

Author keywords

Antiinflammation; Laggera pterodonta; Phytomedicine; Total flavonoids

Indexed keywords

ACETIC ACID; CARRAGEENAN; FLAVONOID; GLUTATHIONE PEROXIDASE; HERBACEOUS AGENT; LAGGERA PTERODONTA EXTRACT; LYSOZYME; MALONALDEHYDE; NITRIC OXIDE; PLANT EXTRACT; PROSTAGLANDIN E2; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; XYLENE;

ACUTE TOXICITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTERACEAE; BLOOD VESSEL PERMEABILITY; CHRONIC INFLAMMATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; EDEMA; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME INHIBITION; GRANULOMA; IN VIVO STUDY; INFLAMMATION; LAGGERA PTERODONTA; LEUKOCYTE MIGRATION INHIBITION; MALE; MOUSE; NONHUMAN; PLEURISY; PROSTAGLANDIN SYNTHESIS INHIBITION; RAT;

ACUTE DISEASE; ANIMALS; ANTI-INFLAMMATORY AGENTS; ASTERACEAE; CARRAGEENAN; CHRONIC DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; FLAVONOIDS; INFLAMMATION; MALE; MICE; MICE, INBRED ICR; RATS; RATS, SPRAGUE-DAWLEY; XYLENES;

GOSSYPIUM HIRSUTUM; LAGGERA PTERODONTA;

EID: 33746014145     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.1918     Document Type: Article

References (30)

1. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. 1990. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 87: 1620-1624.
2. Cuzzocrea S, Zingarelli B, Guard E, Hake P, Salzman AL, Szabo C. 1998. Anti-inflammatory effects of mercaptoethylguanidine, a combined inhibitor of nitric oxide synthase and peroxynitrite scavenger, in carrageenan-induced models of inflammation. Free Radic Biol Med 24: 450-459.
3. Dawson J, Sedgwick AD, Edwards JC, Lees P. 1991. A comparative study of the cellular, exudative and histological responses to carrageenan, dextran and zymosan in mouse. Int J Tissue React 13: 171-185.
4. Deng SX. 1963. Defervescence and removing phlegm activities in Laggera pterodonta. J Yunnan Med 2: 28-30.
5. Harada Y, Tanaka K, Uchida Y et al. 1982. Changes in the levels of prostaglandins and thromboxane and their roles in the accumulation of exudate in rat carrageenin-induced pleurisy - a profile analysis using gas chromatography-mass spectrometry. Prostaglandins 23: 881-895.
6. Heiman AS, Taraporewala IB, Lee HJ. 1989. Local antiinflammatory activity of steroid-21-oate esters in the carrageenan pleurisy model of acute inflammation. Drug Dev Res 17: 153-160.
7. Jiangsu New Medical College. 1977. A Dictionary of Traditional Chinese Drugs (1st edn). Shanghai People's Press: Shanghai, 3882.
8. Li SL, Ding JK. 1994. The flavonols from Laggera pterodonta. Acta Bot Yunnan 16: 434-436.
9. Li YL, Ooil LSM, Wang H, But PPH, Ooil VEC. 2004. Antiviral activities of medicinal herbs traditionally used in southern mainland China. Phytother Res 18: 718-722.
10. Mikami T, Miyasaka K. 1983. Effect of several anti-inflammatory drugs on the various parameters involved in the inflammation response in rat carrageenan-induced pleurisy. Eur J Pharmacol 95: 1-12.
11. Moncada S, Palmer RMJ, Higgs EA. 1991. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 43: 109-142.
12. Oh-ishi S, Hayashi I, Hayashi M, Yamaki K, Utsunomiya I. 1989. Pharmacological demonstration of inflammatory mediators using experimental inflammatory models: rat pleurisy induced by carrageenin and phorbol myristate acetate. Dermatologica 179 (Suppl 1): 68-71.
13. Pelzer LE, Guardia T, Juarez AO, Guerreiro E. 1998. Acute and chronic anti-inflammatory effects of plant flavonoids. Farmaco 53: 421-424.
14. Rubbo H, Radi R, Trujilli M et al. 1994. Nitric oxide regulation of superoxide and peroxynitrite-dependent lipid peroxidation. J Biol Chem 269: 26066-26075.
15. Selye H. 1953. On the mechanism through which hydrocorticosterone affects the resistance of tissues to injury. An experimental study with granuloma pouch techniques. J Am Med Assoc 152: 1207-1213.
16. Subbaramaiah K, Zakim D, Wekaler BB, Dannenberg JA. 1997. Inhibition of cyclooxygenase. A novel approach to cancer prevention. Proc Soc Exp Biol Med 216: 201-210.
17. Torel J, Cillard J, Cillard P. 1986. Antioxidant activity of flavonoids and reactivity with peroxy radical. Phytochemistry 25: 383-385.
18. Vinegar R, Truax JF, Selph JL, Johnston PR, Venable AL, Mokenzic KK. 1987. Pathway to carrageenan-induced inflammation in the hind limb of the rat. Fed Proc 46: 118-126.
19. Vinegar R, Truax JF, Voelker FA. 1982. Pathway of onset, development and decay of carrageenan pleurisy in the rat. Fed Proc 41: 2588-2595.
20. Wei JX, Zhao AH, Hu JL, Zhu Y. 1995. Study on chemical constituents of Laggera pterodonta. Acad J Kunming Med Coll 16: 83-84.
21. Whittle BA. 1964. The use of changes in capillary permeability in mice to distinguish between narcotic and nonnarcotic analgesics. Br J Pharmacol 22: 246-253.
22. Williams CH, Hoult JRS, Harborne JB, Greenham J, Eagles J. 1995. A biologically active lipophilic flavonol from Tanacetum parthenium. Phytochemistry 38: 267-270.
23. Winter CA, Porter CC. 1957. Effects of alterations in side chain upon anti-inflammatory and liver glycogen activities of hydrocortisone esters. J Am Pharm Assoc Sci Ed 46: 515-519.
24. Winter CA, Risley EA, Nuss GW. 1962. Carrageenan-induced oedema in hind paw of the rat as an assay for antiinflammatory drugs. Proc Soc Exp Biol Med 111: 544-547.
25. Wu YJ. 1991. Anti-inflammatory mechanism of sodium glycyrrhetinate. Chin Pharmacol Bull 7: 46-49.
26. Xiao YC, Zheng QX, Zhang QJ, Sun HD, Guéritte F, Zhao Y. 2003. Eudesmane derivatives from Laggera pterodonta. Fitoterapia 74: 459-463.
27. Young JM, De Young LM. 1989. Cutaneous models of inflammation for the evaluation of topical and systemic pharmacological agents. In Pharmacological Methods in the Control of Inflammation, Spector J, Back N (eds). Liss: New York, 215-231.
28. Zhao Y, Yue JM, Lin ZW, Ding JK, Sun HD. 1997a. Eudesmane sesquiterpenes from Laggera pterodonta. Phytochemistry 44: 459-464.
29. Zhao Y, Yue JM, Lin ZW, Sun HD. 1997b. Eleven new eudesmane derivatives from Laggera pterodonta. J Nat Prod 60: 545-549.
30. Zhao Y, Yue JM, Lin ZW, Wang DZ, Ding JK, Sun HD. 1997c. Five new eudesmane derivatives from Laggera pterodonta. Acta Bot Yunnan 19: 207-210.